Pfizer SARS-CoV-2 protease inhibitor PF-07321332 and SARS-CoV-2 protease, molecular models. The image shows the protease (top) and the inhibitor (bottom). As of 2021, the clinical candidate PF-07321332 is a potent protease inhibitor with potent anti-viral activity against SARS-CoV-2. | |
Licence : | Droits gérés |
Crédit: | Science Photo Library / Laguna Design |
Taille de l’image : | 5000 px × 3750 px |
Model Release : | Non requis |
Property Release : | Non requis |
Restrictions : | - |